ArticleAging cell2026
Liver- and Immune-Enriched Molecular Signatures Associated With Mortality in Older Adults.
Article in Aging cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Quantifying biological aging requires biomarkers that capture multisystem physiological decline beyond chronological age. We aimed to compare the prognostic performance of plasma proteomics, metabolomics, and conventional clinical risk factors for all-cause mortality, and to characterize molecular pathways associated with mortality risk and age-related physiological decline. Untargeted plasma proteomics and metabolomics were profiled in 848 community-dwelling adults from the I-Lan Longitudinal Aging Study (ILAS), followed for a mean of 8.5 years, during which 92 deaths occurred. Cox proportional hazards models were applied to identify mortality-associated molecular features and their enriched biological pathways. We identified 79 proteins associated with all-cause mortality (FDR < 0.1), predominantly liver-derived and immune-related. Pathway analysis revealed coordinated dysregulation across coagulation cascades, complement activation, oxidative stress responses, glucose metabolism, and bile acid metabolism. Elastic net regression was subsequently used to construct omics-based mortality risk scores, which were further evaluated in an independent validation cohort from the Longitudinal Aging Study of Taipei (LAST). A 20-protein mortality score achieved strong discrimination (C-index 0.81), outperforming metabolite-based models (C-index 0.77) and clinical risk factors (C-index 0.73) in the discovery cohort. In the external validation cohort, both proteomic- and metabolomic-derived scores showed directionally consistent associations with mortality risk. Together, these findings identify liver- and immune-enriched molecular signatures associated with mortality risk in older adults and support the utility of plasma multi-omics profiling as a scalable precision tool for biological age assessment. The identified proteomic and metabolomic pathways may help inform future interventions targeting systemic aging and age-related functional decline.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.